Norman D. Schwartz
Net Worth
Last updated:
What is Norman D. Schwartz net worth?
The estimated net worth of Mr. Norman D. Schwartz is at least $357,349,481 as of 1 Nov 2023. He owns shares worth $235,931,160 as insider, has earned $1,018,321 from insider trading and has received compensation worth at least $120,400,000 in Bio-Rad Laboratories, Inc. and Bio-Rad Laboratories, Inc..
What is the salary of Norman D. Schwartz?
Mr. Norman D. Schwartz salary is $3,010,000 per year as Chairman, Chief Executive Officer & Pres in Bio-Rad Laboratories, Inc.. He also receives $3,010,000 as Chairman, Chief Executive Officer & Pres in Bio-Rad Laboratories, Inc..
How old is Norman D. Schwartz?
Mr. Norman D. Schwartz is 75 years old, born in 1950.
What stocks does Norman D. Schwartz currently own?
As insider, Mr. Norman D. Schwartz owns shares in 2 companies:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Bio-Rad Laboratories, Inc. (BIO) | Chairman, Chief Executive Officer & Pres | 411,252 | $286.14 | $117,675,647 |
| Bio-Rad Laboratories, Inc. (BIO-B) | Chairman, Chief Executive Officer & Pres | 411,252 | $287.55 | $118,255,513 |
What does Bio-Rad Laboratories, Inc. do?
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents, instruments, and software, which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. In addition, the company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
What does Bio-Rad Laboratories, Inc. do?
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents, instruments, and software, which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. In addition, the company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
Norman D. Schwartz insider trading
Bio-Rad Laboratories, Inc.
Mr. Norman D. Schwartz has made 3 insider trades between 2005-2023, according to the Form 4 filled with the SEC.
The largest trade he's ever made was exercising 76,913 units of BIO stock on 25 Aug 2015. As of 1 Nov 2023 he still owns at least 411,252 units of BIO stock.
Bio-Rad Laboratories, Inc.
Mr. Norman D. Schwartz has made 3 insider trades between 2005-2022, according to the Form 4 filled with the SEC.
The largest trade he's ever made was exercising 76,913 units of BIO-B stock on 25 Aug 2015. As of 1 Nov 2023 he still owns at least 411,252 units of BIO-B stock.
Bio-Rad Laboratories key executives
Bio-Rad Laboratories, Inc. executives and other stock owners filed with the SEC:
- Dr. Andrew J. Last (65) Executive Vice President & Chief Operating Officer
- Mr. Ilan Daskal (59) Executive Vice President & Chief Financial Officer
- Mr. Norman D. Schwartz (75) Chairman, Chief Executive Officer & Pres
- Ms. Dara Grantham Wright (49) Executive Vice President & Pres of Clinical Diagnostics Group